Total Payments
$2.9M
2024 Payments
$456,895
Companies
33
Transactions
4,316
Payment Breakdown by Category
Other$2.3M (78.4%)
Travel$453,401 (15.6%)
Consulting$110,984 (3.8%)
Food & Beverage$63,664 (2.2%)
Education$390.75 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.3M | 1,018 | 78.3% |
| Travel and Lodging | $453,401 | 1,645 | 15.6% |
| Consulting Fee | $110,984 | 48 | 3.8% |
| Food and Beverage | $63,664 | 1,589 | 2.2% |
| Honoraria | $2,750 | 1 | 0.1% |
| Education | $390.75 | 15 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $534,137 | 761 | $0 (2024) |
| Allergan, Inc. | $522,597 | 904 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $482,092 | 553 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $310,909 | 426 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $251,039 | 334 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $226,820 | 303 | $0 (2024) |
| Merck Sharp & Dohme LLC | $127,053 | 214 | $0 (2022) |
| ITI, Inc. | $93,865 | 141 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $84,507 | 125 | $0 (2023) |
| Alkermes, Inc. | $73,389 | 113 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $456,895 | 584 | ABBVIE INC. ($160,038) |
| 2023 | $433,120 | 583 | ABBVIE INC. ($164,055) |
| 2022 | $421,900 | 609 | Neurocrine Biosciences, Inc. ($114,486) |
| 2021 | $369,663 | 481 | AbbVie Inc. ($106,994) |
| 2020 | $221,696 | 320 | Allergan, Inc. ($103,681) |
| 2019 | $358,557 | 617 | Allergan Inc. ($119,289) |
| 2018 | $344,280 | 621 | Allergan Inc. ($155,052) |
| 2017 | $301,216 | 501 | Allergan Inc. ($134,495) |
All Payment Transactions
4,316 individual payment records from CMS Open Payments — Page 1 of 173
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,769.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/27/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,145.00 | General |
| Category: Neuroscience | ||||||
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $63.59 | General |
| 12/23/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: Neurology | ||||||
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.38 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,984.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/18/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $16.08 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $97.45 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $1.34 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $1.34 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,215.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Travel and Lodging | Cash or cash equivalent | $5.36 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $71.02 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/03/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $6.74 | General |
| Category: Neurology | ||||||
| 12/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/02/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/02/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: CNS | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $101.66 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $81.60 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Jeffrey Hansen, M.D
Dr. Jeffrey Hansen, M.D is a Psychiatry healthcare provider based in Vancouver, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356410419.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Hansen, M.D has received a total of $2.9M in payments from pharmaceutical and medical device companies, with $456,895 received in 2024. These payments were reported across 4,316 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2.3M).
Ad
Practice Information
- Specialty Psychiatry
- Location Vancouver, WA
- Active Since 11/06/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1356410419
Products in Payments
- VRAYLAR (Drug) $1.1M
- INGREZZA (Drug) $477,343
- REXULTI (Drug) $269,502
- SPRAVATO (Drug) $251,143
- AUSTEDO (Drug) $183,295
- Trintellix (Drug) $127,433
- BELSOMRA (Drug) $127,023
- CAPLYTA (Drug) $117,261
- LYBALVI (Drug) $73,010
- Auvelity (Drug) $53,843
- ABILIFY MAINTENA (Drug) $41,894
- SUNOSI (Drug) $33,057
- UZEDY (Drug) $21,788
- Austedo XR (Drug) $21,535
- QELBREE (Drug) $11,929
- Qelbree (Drug) $11,813
- COBENFY (Drug) $10,678
- LATUDA (Drug) $3,514
- Dayvigo (Drug) $2,327
- Azstarys (Drug) $2,327
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Vancouver
Elia Gonzalez-Rodriguez, Md, MD
Psychiatry — Payments: $3,802
Psychiatry $3,802
Dr. Michael Domash, M.d, M.D
Psychiatry — Payments: $3,025
Psychiatry $3,025
Dr. Daniel Lam, Md, MD
Psychiatry — Payments: $2,865
Psychiatry $2,865
Dr. Jerald Block, Md, MD
Psychiatry — Payments: $2,751
Psychiatry $2,751
Dr. George Moses, D.o, D.O
Psychiatry — Payments: $2,202
Psychiatry $2,202
Karen Chu, Md, MD
Psychiatry — Payments: $555.67
Psychiatry $555.67